Table 4.
Gene | Genotype | Phenotype | Ref. |
---|---|---|---|
RB1CC1 or FIP200 | Tek-Cre;rb1cc1f/f | Perinatal lethal from severe erythroblastic anemia. | [15] |
rb1cc1f/+;p62+/− | Viable; mammary tumor growth severely impaired in FIP200-null compared with FIP200 and p62 double-knockout mice. | [15] | |
rb1cc1−/− | Embryonic lethal at E14.5–15.5. | [15] | |
rb1cc1f/f;MMTV-Cre;MMTV-PyMT | Develop palpable mammary tumor with T50 of 85d; >60% decrease in epithelial surface covered by hyperplastic nodules and 2.5-fold reduction in the average mass of the mammary glands compared with that for rb1cc1f/f;MMTV-PyMT mice. | [82] | |
rb1cc1f/+;MMTV-Cre;MMTV-PyMT | Develop palpable mammary tumor with T50 of 62d. | [82] | |
rb1cc1f/f;MMTV-PyMT | Develop palpable mammary tumor with T50 of 56d. | [82] | |
Beclin-1 | Becn1+/−;MMTV-Wnt1 | Display significantly shorter mammary tumor-free survival (4 vs. 7.2 months) and overall survival compared with Becn1+/+;MMTV-Wnt1. | [83] |
Tsc1 | tsc1f/f;MMTV-PyMT | Viable | [25] |
aModified from Table 2 of [15].